8.2% Genelux (NASDAQ: GNLX) stake disclosed by holder Aladar Szalay

Rhea-AI Filing Summary

Aladar Szalay filed an amended Schedule 13G reporting beneficial ownership of 3,134,286 shares of Genelux Corp common stock, representing 8.2% of the company. This percentage is based on 38,051,771 shares outstanding as of October 30, 2025, as disclosed in Genelux’s Form 10-Q.

The filing shows 1,149,821 shares with sole voting and dispositive power, mainly through two Szalay family trusts, and 1,984,465 shares with shared voting and dispositive power, held by the Szalay Trust dated August 30, 2021 and the reporting person’s spouse. The event date triggering the filing is December 31, 2025.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

GENELUX CORP

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

36870H103

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 36870H103

1

Names of Reporting Persons

Aladar Szalay

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,149,821.00
6	Shared Voting Power 1,984,465.00
7	Sole Dispositive Power 1,149,821.00
8	Shared Dispositive Power 1,984,465.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,134,286.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.2 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: GENELUX CORP
(b)	Address of issuer's principal executive offices: 2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361.
Item 2.
(a)	Name of person filing: Aladar Szalay
(b)	Address or principal business office or, if none, residence: 7704 North Fork Rd., Highland, CA 92346
(c)	Citizenship: United States
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 36870H103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See Row 9 of cover page. Consists of (i) 599,821 shares of common stock held by The Szalay 2010 Retained Annuity Trust, (ii) 550,000 shares of common stock held by The Szalay 2010 Children's Trust, for which the reporting person has sole voting and dispositive power, (iii) 5,000 shares of common stock held by the reporting person's spouse and (iv) 1,979,465 held by Szalay Trust Dated August 30th 2021, for which the reporting person has shared voting and dispositive power.
(b)	Percent of class: See Row 11 of cover page. This percentage is calculated based on 38,051,771 shares of common stock outstanding as of October 30, 2025, as reported in Genelux Corporation's Form 10-Q, filed with the Securities and Exchange Commission on November 5, 2025.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Row 5 of cover page for the Reporting Person. Consists of (i) 599,821 shares of common stock held by The Szalay 2010 Retained Annuity Trust and (ii) 550,000 shares of common stock held by The Szalay 2010 Children's Trust, for which the reporting person has sole voting and dispositive power.
	(ii) Shared power to vote or to direct the vote: See Row 6 of cover page for the Reporting Person. Consists of 5,000 shares of common stock held by the reporting person's spouse and 1,979,465 held by Szalay Trust Dated August 30th 2021, for which the reporting person has shared voting and dispositive power.
	(iii) Sole power to dispose or to direct the disposition of: See Row 7 of cover page for the Reporting Person. Consists of (i) 599,821 shares of common stock held by The Szalay 2010 Retained Annuity Trust and (ii) 550,000 shares of common stock held by The Szalay 2010 Children's Trust, for which the reporting person has sole voting and dispositive power.
	(iv) Shared power to dispose or to direct the disposition of: See Row 8 of cover page for the Reporting Person. Consists of 5,000 shares of common stock held by the reporting person's spouse and 1,979,465 held by Szalay Trust Dated August 30th 2021, for which the reporting person has shared voting and dispositive power.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Aladar Szalay

Signature:	/s/ Aladar Szalay
Name/Title:	Aladar Szalay
Date:	02/17/2026

FAQ

What stake in Genelux Corp (GNLX) does Aladar Szalay report?

Aladar Szalay reports beneficial ownership of 3,134,286 Genelux Corp common shares, equal to 8.2% of the company. This ownership is calculated against 38,051,771 shares outstanding as of October 30, 2025, as referenced from Genelux’s Form 10-Q filing.

How is Aladar Szalay’s Genelux (GNLX) ownership structured in the Schedule 13G/A?

Szalay’s reported holdings include 1,149,821 shares with sole voting and dispositive power and 1,984,465 shares with shared power. The sole-power shares are held via two Szalay family trusts, while the shared-power shares are held by the Szalay Trust dated August 30, 2021 and his spouse.

What percentage of Genelux (GNLX) shares does 3,134,286 represent?

The 3,134,286 Genelux shares beneficially owned by Aladar Szalay represent 8.2% of the outstanding common stock. This percentage uses 38,051,771 shares outstanding as of October 30, 2025, as reported in Genelux Corporation’s Form 10-Q filed with the SEC.

When is the event date for Aladar Szalay’s Schedule 13G/A on Genelux (GNLX)?

The Schedule 13G/A lists December 31, 2025 as the date of the event requiring the filing. This event date marks when Szalay’s beneficial ownership position met the threshold that triggered the updated beneficial ownership disclosure for Genelux common stock.

Which entities hold Genelux (GNLX) shares for Aladar Szalay according to the filing?

The filing states that shares are held by The Szalay 2010 Retained Annuity Trust, The Szalay 2010 Children’s Trust, the Szalay Trust dated August 30, 2021, and Szalay’s spouse. These holdings collectively make up the 3,134,286 Genelux common shares reported as beneficially owned.